Search
Login
Register
Menu
BJH
Home
News
Newsroom
Links
CongressUpdate
Guidelines
Specials
Hematotrials
Patients
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: What do we still need to know about the treatment of RCC?
“1 year subscription print edition of the Belgian Journal of Hematology (BJH)” has been added to your cart.
View cart
Article: What do we still need to know about the treatment of RCC?
€
2.42
Article: What do we still need to know about the treatment of RCC? quantity
Add to cart
SKU:
product-article-10861
Category:
General
Description
Description
What do we still need to know about the treatment of RCC?
Related products
Article: Highlights in digestive oncology
€
2.42
Add to cart
Article: INTRODUCTION
€
2.42
Add to cart
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€
2.42
Add to cart
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€
2.42
Add to cart